Normal pressure hydrocephalus triggers intrathecal production of TNF-α

Neurobiology of Aging

Volumn 24, Issue 5, 2003, Pages 707-714

  Tarkowski, E ^a   Tullberg, M ^a   Fredman, P ^a   Wikkelso C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Cytokines; Normal pressure hydrocephalus; Periventricular edema; Sulfatide; Tumor necrosis factor ; White matter hyperintensity changes

Indexed keywords

SULFATIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MYELIN DEFICIENCY; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMETRY; SHUNTING; SYMPTOMATOLOGY; TREATMENT OUTCOME; WAKEFULNESS; WHITE MATTER; BRAIN; BRAIN MAPPING; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTING; COMPARATIVE STUDY; GAIT; INSTRUMENTATION; MENTAL HEALTH; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBROSPINAL FLUID SHUNTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAIT; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; SULFOGLYCOSPHINGOLIPIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041883789     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00187-2     Document Type: Article

References (48)

1. Adams R.D., Fisher C.M., Hakim S., Ojeman R.G., Sweet W.H. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrome. N. Engl. J. Med. 273:1965;117-126.
2. Akai K., Uchigasaki S., Tanaka U., Komatsu A. Normal pressure hydrocephalus. Neuropathological study. Acta. Pathol. Jpn. 37:1987;97-110.
3. Bitsch A., Kuhlmann T., Da Costa C., Bunkowski S., Polak T., Bruck W. Tumor necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia. 29:2000;366-375.
4. Blomsterwall E., Bilting M., Stephensen H., Wikkelsö C. Gait abnormality is not the only motor disturbance in normal pressure hydrocephalus. Scand. J. Rehabil. Med. 27:1995;205-209.
5. Bradley W.G. Jr., Whittemore A.R., Watanabe A.S., Davis S.J., Teresi L.M., Homyak M. Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus [see comments]. Am. J. Neuroradiol. 12:1991;31-39.
6. Coet T., Suzuki K., Popko B. New perspectives on the function of myelin galactolipids. TINS. 21:1998;126-130.
7. D'Souza S., Alinauskas K., McCrea E., Goodyer C., Antel J.P. Differential susceptibility of human CNS-derived cell populations to the TNF-dependent and independent immune-mediated injury. J. Neurosci. 15:1995;7293-7300.
8. Davidsson P., Fredman P., Månsson J.-E., Svennerholm L. Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. Clin. Chim. Acta. 197:1991;105-115.
9. Davies L., McLeod J.G., Muir A., Hensley W.J. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness. Clin. Exp. Neurol. 24:1987;5-10.
10. Davis P.C., Mirra S.S., Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. Am. J. Roentgenol. 162:1994;1267-1278.
11. Deo Narine V., Gomez D.G., Vullo T.et al. Direct in vivo observation of transventricular absorption in the hydrocephalic dog using magnetic resonance imaging. Invest. Radiol. 29:1994;287-293.
12. Fredman P., Wallin A., Blennow K., Davidsson P., Gottfries C.G., Svennerholm L. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta. Neurol. Scand. 85:1992;103-106.
13. Godersky J.C., Graff Radford N.R., Yuh W.T. Magnetic resonance imaging of patients with normal pressure hydrocephalus. Adv. Neurol. 52:1990;554.
14. Graff Radford N.R., Rezai K., Godersky J.C., Eslinger P., Damasio H., Kirchner P.T. Regional cerebral blood flow in normal pressure hydrocephalus. J. Neurol. Neurosurg. Psychiatry. 50:1987;1589-1596.
15. Gupta M.K. Myelin basic protein and demyelinating diseases. Crit. Rev. Clin. Lab. Sci. 24(4):1987;287-314.
16. Hakim S., Adams R.D. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J. Neurol. Sci. 2:1965;307-327.
17. Hayley S., Bredner K., Lacosta S., Merali Z., Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 19:1999;5654-5665.
18. Holmin S., Mathiesen T. Intracerebral administration of interleukin-1-beta induces neuronal DNA-fragmentation, encephalitis and vasogenic edema. J. Neurosurg. 92:2000;108-120.
19. Karlsson J.-E., Rosengren L.E., Haglid K.G. Quantitative and qualitative alterations of neuronal and glial intermediate filaments in rat nervous system after exposure to 2,5-hexanedione. J. Neurochem. 57:1991;1437-1444.
20. Krauss J.K., Droste D.W., Vach W.et al. Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesions. Neurosurgery. 39:1996;292-299.
21. Larsson A., Bergh A.C., Bilting M., Jacobsson L., Stephensen H., Wikkelsö C. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur. J. Nucl. Med. 21:1994;118-123.
22. Larsson A., Moonen M., Bergh A.C., Lindberg S., Wikkelsö C. Predictive value of quantitative cisternography in normal pressure hydrocephalus. Acta. Neurol. Scand. 81:1990;327-332.
23. Larsson A., Wikkelsö C., Bilting M., Stephensen H. Clinical parameters in 74 consecutive patients shunt operated for normal pressure hydrocephalus. Acta. Neurol. Scand. 84:1991;475-482.
24. Lee M.K., Cleveland D.W. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19:1996;187-217.
25. Lieberman A.P., Pitha P.M., Shin H.S., Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotrop virus. Proc. Natl. Acad. Sci. U.S.A. 86:1989;6348-6352.
26. Lindquist G., Malmgren H. Classification and diagnosis of organic mental disorders. Acta Psychiatr. Scand. 88(Suppl):1993;373.
27. Lindquist G., Andersson H., Bilting M., Blomstrand C., Malmgren H., Wikkelsö C. Normal pressure hydrocephalus: psychiatric findings before and after shunt operation classified in a new diagnostic system for organic psychiatry. Acta Psychiatr. Scand. Suppl. 373:1993;18-32.
28. McLaurin J., D'Souza S., Stewart J., Blain M., Beaudet A., Nalbantoglu J.et al. Effect of tumor necrosis factor α and β on humans oligodendrocytes and neurons in culture. Int. J. Dev. Neurosci. 13:1995;369-381.
29. Milhorat T.H., Clark R.G., Hammock M.K., McGrath P.P. Structural, ultrastructural, and permeability changes in the ependyma and surrounding brain favoring equilibration in progressive hydrocephalus. Arch. Neurol. 22:1970;397-407.
30. Milhorat T.H. The third circulation revisited. J. Neurosurg. 42:1975;628-645.
31. Miyagami M, Shibuya T, Tsubokawa T. Subependymal CSF absorption in hydrocephalic edema. In: Matsumoto S, Tamaki N, editors. Hydrocephalus, pathogenesis and treatment. Tokyo: Springer Verlag; 1981. p. 181-94.
32. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
33. Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A.D.et al. Monokine production by microglial cell clones. Eur. J. Immunol. 19:1989;1443-1448.
34. Rosengren B., Fredman P., Månsson J.-E., Svennerholm L. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain. J. Neurochem. 52:1989;1035-1041.
35. Rosengren L.E., Karlsson J.-E., Karlsson J.-O., Persson L.I., Wikkelsö C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J. Neurochem. 67:1996;2017-2020.
36. Selmaj K., Raine C.S., Cannela B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
37. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
38. Sutton L.N., Wood J.H., Brooks B.R., Barrer S.J., Kline M., Cohen S.R. Cerebrospinal fluid myelin basic protein in hydrocephalus. J. Neurosurg. 59:1983;467-470.
39. Svennerholm L., Boström K., Fredman P., Månsson J.-E., Rynmark B.-M. Membrane lipids of human peripheral nerve and spinal cord. Biochim. Biophys. Acta. 1128:1992;1-7.
40. Tarkowski E., Rosengren L.E., Blomstrand C., Wikkelsö C., Jensen C., Ekholm S.et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 26:1995;1393-1398.
41. Tarkowski E., Wallin A., Blennow K., Tarkowski A. Local production of TNF-α, a potent neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19:1999;223-230.
42. Tracey KJ. Tumor necrosis factor-alpha. In: Thomson AW, editor. The cytokine handbook, vol. 19. 2nd ed. London: Academic Press; 1994. p. 343-69.
43. Tullberg M., Hultin L., Ekholm S., Månsson J.-E., Fredman P., Wikkelsö C. White matter changes in normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta. Neurol. Scand. 105:2002;417-426.
44. Tullberg M., Månsson J.-E., Fredman P., Lekman A., Blennow K., Ekman R.et al. CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy. J. Neurol. Neurosurg. Psychiatry. 69:2000;74-81.
45. Wang S., Lees G.J., Rosengren L.E.et al. The effect of an N-methyl-D-aspartate lesion in the hippocampus on glial and neuronal marker proteins. Brain Res. 541:1991;334-341.
46. Weller R.O., Wisniewski H., Shulman K. Experimental hydrocephalus in young dogs. J. Neuropathol. Exp. Neurol. 30:1971;613-626.
47. Wikkelsö C., Andersson H., Blomstrand C., Lindqvist G., Svendsen P. Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test. Acta. Neurol. Scand. 73:1986;566-573.
48. Yoon B.H., Romero R., Kim C.J., Koo J.N., Choe G., Syn H.C.et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am. J. Obstet. Gynecol. 177:1997;406-411.